EFFICACY AND SAFETY OF â??AYUR RAKSHA KITâ?? IN MILD COVID-19 PATIENTS AT A TERTIARY CARE HOSPITAL: AN OPEN-LABEL, RANDOMIZED CONTROL STUDY

Dr VISHWA SANTHOSHA BHARATHI0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1.Patients willing to give written informed consent
•2.Patients of either sex aged between 18 and 60 years.
•3.Patients diagnosed with COVID-19 positive (confirmed by RT-PCR)
•Mild symptomatic patients (Patients with uncomplicated upper respiratory tract infection) such as:
•SpO2: >=94% in room air
•RR: <= 24/m
•No evidence of hypoxemia or breathlessness

•1.Patients who is not willing to give consent for the study.
•2.Patients who has uncontrolled comorbidities like Diabetes, Hypertension and heart diseases.
•3.Patients with pre-existing respiratory conditions, renal and liver diseases.
•4.Immunocompromised individuals/those on immunosuppressants.
•5.Female patients who are pregnant/ lactating or considering pregnancy.
•6.Psychiatric or emotional disturbance in patients which would limit ability of the patients to comply.

发起方

Dr VISHWA SANTHOSHA BHARATHI